These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16294540)

  • 1. [Secondary prevention of myocardial infarction in the Basse-Normandie region].
    Pédaillès S; Kühn F; Grollier G; Thielly P
    Arch Mal Coeur Vaiss; 2005 Oct; 98(10):960-5. PubMed ID: 16294540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention of myocardial infarction in the Ile de France].
    Bérigaud E; Silvera L; Du Bron D; Dupont-Zacot E; Chabry C; Trutt B; Blanchon B; Parmentier M; Hecquard P
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):150-6. PubMed ID: 11998328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term effects of prescription drugs in 174 patients treated for myocardial infarction, followed up from 4 to 5 years (the DEVENIR study)].
    Graille V; Ferrières J; Marques-Vidal P; Ruidavets JB; Rodier P; Cambou JP
    Arch Mal Coeur Vaiss; 1996 Jan; 89(1):35-9. PubMed ID: 8678736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of acute transmural myocardial infarction: a study on 200 patients admitted to a tertiary care medical center].
    Kassab R; Rachoin JS; Azar R; Salamé E
    J Med Liban; 2005; 53(1):2-8. PubMed ID: 16398206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction.
    Jackevicius CA; Li P; Tu JV
    Circulation; 2008 Feb; 117(8):1028-36. PubMed ID: 18299512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.
    Tuppin P; Neumann A; Danchin N; Weill A; Ricordeau P; de Peretti C; Allemand H
    Arch Cardiovasc Dis; 2009 Apr; 102(4):279-92. PubMed ID: 19427605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)].
    Béraut E; Cambou JP; Guilhem JM; Vaysse N; Labro S; Séverac D; Boccalon H; Bura-Rivière A
    J Mal Vasc; 2008 Feb; 33(1):1-11. PubMed ID: 18187280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention of myocardial infarction in Spain. The PREVERSE study].
    de Velasco JA; Cosín J; López Sendón JL; de Teresa E; de Oya M; Carrasco JL; Navarro A
    Rev Esp Cardiol; 1997 Jun; 50(6):406-15. PubMed ID: 9304163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E; Pettersen KI; Landmark K; Reikvam A;
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug prescription in the postinfarction period; results of the EPPI II (Study of Postinfarct Prescription). A French cooperative study].
    Boissel JP; Némoz C; Leizorovicz A; Gillet J
    Arch Mal Coeur Vaiss; 1995 Sep; 88(9):1261-6. PubMed ID: 8526704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of coronary bypass grafting in a population of middle-aged men.
    Dudas KA; Wilhelmsen L; Rosengren A
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):122-7. PubMed ID: 17301637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of clinical characteristics and management of patients with ST segment elevation myocardial infarction at atertiary care center.
    Sánchez M; Cox RA; Rodríguez JM; Pérez CM
    P R Health Sci J; 2006 Sep; 25(3):219-24. PubMed ID: 17203791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduction in acute myocardial infarction mortality over a five-year period].
    Heras M; Marrugat J; Arós F; Bosch X; Enero J; Suárez MA; Pabón P; Ancillo P; Loma-Osorio A; Rodríguez JJ; Subirana I; Vila J;
    Rev Esp Cardiol; 2006 Mar; 59(3):200-8. PubMed ID: 16712743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
    Austin PC; Mamdani MM; Juurlink DN; Alter DA; Tu JV
    Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.